vs
Side-by-side financial comparison of COMERICA INC (CMA) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $838.0M, roughly 1.3× COMERICA INC). COMERICA INC runs the higher net margin — 21.0% vs -127.8%, a 148.8% gap on every dollar of revenue. On growth, COMERICA INC posted the faster year-over-year revenue change (3.3% vs -2.5%). Over the past eight quarters, COMERICA INC's revenue compounded faster (108.9% CAGR vs 1.3%).
Comerica Incorporated is an American financial services company, headquartered in Dallas, Texas. It is the parent of Comerica Bank, a regional commercial bank with 413 branches in the U.S. states of Texas, Michigan, California, Florida and Arizona. Comerica is among the largest U.S. financial holding companies, with offices in a number of U.S. cities.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
CMA vs PRGO — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $838.0M | $1.1B |
| Net Profit | $176.0M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | — | -116.0% |
| Net Margin | 21.0% | -127.8% |
| Revenue YoY | 3.3% | -2.5% |
| Net Profit YoY | -4.3% | -3093.9% |
| EPS (diluted) | $1.35 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.1B | ||
| Q3 25 | $838.0M | $1.0B | ||
| Q2 25 | $849.0M | $1.1B | ||
| Q1 25 | $829.0M | $1.0B | ||
| Q4 24 | $825.0M | $1.1B | ||
| Q3 24 | $811.0M | $1.1B | ||
| Q2 24 | $824.0M | $1.1B | ||
| Q1 24 | $784.0M | $1.1B |
| Q4 25 | — | $-1.4B | ||
| Q3 25 | $176.0M | $7.5M | ||
| Q2 25 | $199.0M | $-8.4M | ||
| Q1 25 | $172.0M | $-6.4M | ||
| Q4 24 | $170.0M | $-44.4M | ||
| Q3 24 | $184.0M | $-21.0M | ||
| Q2 24 | $206.0M | $-108.4M | ||
| Q1 24 | $138.0M | $2.0M |
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
| Q4 25 | — | -116.0% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | — | 4.3% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | 10.0% | ||
| Q3 24 | — | 7.4% | ||
| Q2 24 | — | -2.5% | ||
| Q1 24 | — | -5.1% |
| Q4 25 | — | -127.8% | ||
| Q3 25 | 21.0% | 0.7% | ||
| Q2 25 | 23.4% | -0.8% | ||
| Q1 25 | 20.7% | -0.6% | ||
| Q4 24 | 20.6% | -3.9% | ||
| Q3 24 | 22.7% | -1.9% | ||
| Q2 24 | 25.0% | -10.2% | ||
| Q1 24 | 17.6% | 0.2% |
| Q4 25 | — | $-10.23 | ||
| Q3 25 | $1.35 | $0.05 | ||
| Q2 25 | $1.42 | $-0.06 | ||
| Q1 25 | $1.25 | $-0.05 | ||
| Q4 24 | $1.22 | $-0.32 | ||
| Q3 24 | $1.33 | $-0.15 | ||
| Q2 24 | $1.49 | $-0.79 | ||
| Q1 24 | $0.98 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $5.4B | — |
| Stockholders' EquityBook value | $7.4B | $2.9B |
| Total Assets | $77.4B | $8.5B |
| Debt / EquityLower = less leverage | 0.73× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $432.1M | ||
| Q2 25 | — | $454.2M | ||
| Q1 25 | — | $409.9M | ||
| Q4 24 | — | $558.8M | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $542.8M | ||
| Q1 24 | — | $658.5M |
| Q4 25 | — | — | ||
| Q3 25 | $5.4B | — | ||
| Q2 25 | $5.8B | — | ||
| Q1 25 | $5.7B | — | ||
| Q4 24 | $6.7B | — | ||
| Q3 24 | $6.8B | — | ||
| Q2 24 | $7.1B | — | ||
| Q1 24 | $7.1B | — |
| Q4 25 | — | $2.9B | ||
| Q3 25 | $7.4B | $4.4B | ||
| Q2 25 | $6.9B | $4.5B | ||
| Q1 25 | $7.1B | $4.4B | ||
| Q4 24 | $6.5B | $4.3B | ||
| Q3 24 | $7.4B | $4.6B | ||
| Q2 24 | $6.2B | $4.5B | ||
| Q1 24 | $6.0B | $4.7B |
| Q4 25 | — | $8.5B | ||
| Q3 25 | $77.4B | $10.1B | ||
| Q2 25 | $78.0B | $10.1B | ||
| Q1 25 | $77.6B | $9.8B | ||
| Q4 24 | $79.3B | $9.6B | ||
| Q3 24 | $79.7B | $11.2B | ||
| Q2 24 | $79.6B | $10.4B | ||
| Q1 24 | $79.4B | $10.6B |
| Q4 25 | — | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.84× | — | ||
| Q1 25 | 0.81× | — | ||
| Q4 24 | 1.02× | — | ||
| Q3 24 | 0.92× | — | ||
| Q2 24 | 1.15× | — | ||
| Q1 24 | 1.18× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-270.0M | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | -1.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $175.4M | ||
| Q3 25 | $-270.0M | $51.7M | ||
| Q2 25 | $476.0M | $75.9M | ||
| Q1 25 | $273.0M | $-64.5M | ||
| Q4 24 | $601.0M | $312.6M | ||
| Q3 24 | $1.0B | $42.2M | ||
| Q2 24 | $111.0M | $9.5M | ||
| Q1 24 | $-205.0M | $-1.4M |
| Q4 25 | — | $148.6M | ||
| Q3 25 | — | $29.8M | ||
| Q2 25 | — | $56.7M | ||
| Q1 25 | — | $-90.0M | ||
| Q4 24 | — | $274.9M | ||
| Q3 24 | — | $15.1M | ||
| Q2 24 | — | $-18.9M | ||
| Q1 24 | — | $-26.5M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | — | -8.6% | ||
| Q4 24 | — | 24.2% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | -1.8% | ||
| Q1 24 | — | -2.4% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 2.3% |
| Q4 25 | — | — | ||
| Q3 25 | -1.53× | 6.89× | ||
| Q2 25 | 2.39× | — | ||
| Q1 25 | 1.59× | — | ||
| Q4 24 | 3.54× | — | ||
| Q3 24 | 5.70× | — | ||
| Q2 24 | 0.54× | — | ||
| Q1 24 | -1.49× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMA
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
